Abstract
The effects of 1‐methyl‐3‐propyl‐7‐butylxanthine (MPBX), a xanthine derivative, on idarubicin (IDA)‐induced antitumor activity against P388 leukemia cells (P388) and bone marrow suppression were examined. In P388 tumor‐bearing mice, the combination of MPBX with IDA increased the antitumor activity of IDA. The IDA concentration in the tumors in the MPBX combination group increased by 2.0‐fold compared to the level in the IDA‐alone group. On the other hand, as regards IDA‐induced bone marrow suppression, the combination of MPBX with IDA reduced the decrease in the bone marrow cell number by 30% compared to that in the IDA‐alone group. In addition, the IDA concentration in the bone marrow cells was decreased by the combination of MPBX with IDA. An in vitro experiment showed that MPBX facilitated IDA influx and suppressed IDA efflux in P388 cells. In conclusion, the combination of MPBX with IDA increased the antitumor activity and decreased the bone marrow suppression. Therefore, we expect that the combination of MPBX with IDA will be useful for leukemia chemotherapy.
Keywords: 1‐Methyl‐3‐propyl‐7‐butylxanthine, Idarubicin, Antitumor activity, Adverse reaction, Bone marrow suppression
Full Text
The Full Text of this article is available as a PDF (89.8 KB).
REFERENCES
- 1. ) Sadzuka , Y. , Mochizuki , E. and Takino , Y.Caffeine modulates the antitumor activity and toxic side effects of adriamycin . Jpn. J. Cancer Res. , 84 , 348 – 353 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Sadzuka , Y. , Mochizuki , E. , Iwazaki , A. , Hirota , S. and Takino , Y.Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma‐bearing mice . Biol. Pharm. Bull. , 18 , 159 – 161 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Sadzuka , Y. , Mochizuki , E. and Takino , Y.Mechanism of caffeine modulation of the antitumor activity of adriamycin . Toxicol. Lett. , 75 , 39 – 49 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Sadzuka , Y. , Iwazaki , A. , Miyagishima , A. , Nozawa , Y. and Hirota , S.Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity . Jpn. J. Cancer Res. , 86 , 594 – 599 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. ) Sadzuka , Y. , Iwazaki , A. , Sugiyama , T. , Sawanishi , H. and Miyamoto , K.1‐Methyl‐3‐propyl‐7‐butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin . Jpn. J. Cancer Res. , 89 , 228 – 233 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. ) Sadzuka , Y. , Sugiyama , T. , Sawanishi , H. and Miyamoto , K.Enhanced efficacy of 1‐methyl‐3‐propyl‐7‐butylxanthine on the antitumor activity of doxorubicin against doxorubicin‐resistant P388 leukemia . Cancer Lett. , 138 , 5 – 11 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Fujita , H. , Ogawa , M. , Masaoka , T. , Yamada , K. and Kimura , K.A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline antitumor drug, in patients with acute leukemia . Jpn. J. Cancer Chemother. , 19 , 791 – 798 ( 1992. ). [PubMed] [Google Scholar]
- 8. ) Berman , E. , Heller , G. , Santorsa , J. , McKenzie , S. , Gee , T. , Kempin , S. , Gultati , S. , Andreeff , M. , Kolitz , J. , Gabrilove , J. , Reich , L. , Mayer , K. , Keefe , D. , Trainor , K. , Schluger , A. , Penenberg , D. , Raymond , V. , O'Relly , R. , Jhanwar , S. , Young , C. and Clarkson , B.Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia . Blood , 77 , 1666 – 1674 ( 1991. ). [PubMed] [Google Scholar]
- 9. ) Daghestani , N. A. , Arlin , A. Z. , Leyland‐Jones , B. , Gee , S. T. , Kempin , J. S. , Mertelsmann , R. , Budman , D. , Schulman , P. , Baratz , R. , Williams , L. , Clarkson , D. B. and Young , W. C.Phase I and II clinical and pharmacological study of 4‐demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia . Cancer Res. , 45 , 1408 – 1412 ( 1985. ). [PubMed] [Google Scholar]
- 10. ) Berman , E. , Wittes , E. R. , Leyland‐Jones , B. , Casper . S. E. , Gralla , J. R. , Howard , J. , Williams , L. , Baratz , R. and Young , W. C.Phase I and clinical pharmacology studies of intravenous and oral administration of 4‐demethoxydaunorubicin in patients with advanced cancer . Cancer Res. , 43 , 6096 – 6101 ( 1983. ). [PubMed] [Google Scholar]
- 11. ) Cook , G. , Sharp , R. A. , Tansey , P. and Franklin , I. M.A phase I/II trial of Z‐Dex (oral idarubicin and dexamethasone), an oral equivalent of VAD, as initial therapy at diagnosis or progression in multiple myeloma . Br. J. Haematol. , 93 , 931 – 934 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Sakai , R. , Konno , K. , Yamamoto , Y. , Sanae , F. , Takagi , K. , Hasegawa , T. , Iwasaki , N. , Kakiuchi , M. , Kato , H. and Miyamoto , K.Effects of alkyl substitutions of xanthine skeleton on bronchodilation . J. Med. Chem. , 35 , 4039 – 4044 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Miyamoto , K. , Takagi , K. , Sakai , R. , Wakusawa , S. , Koshiura , R. , Nadai , M. , Apichartpichean , R. and Hasegawa , T.Correlation between hydrophobicity of Nalkylxanthine derivatives and their biological activities on guinea‐pig isolated tracheal smooth muscle . J. Pharm. Pharmacol. , 41 , 844 – 847 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Miyamoto , K. , Sakai , R. , Yamamoto , Y. , Konno , K. , Sanae , F. , Hasegawa , T. and Takagi , K.Selective bronchodilators from 1‐(5′‐oxohexyl)xanthines . J. Pharm. Pharmacol. , 44 , 888 – 892 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Miyamoto , K. , Yamamoto , Y. , Kurita , M. , Sakai , R. , Konno , K. , Sanae , F. , Ohshima , T. , Takagi , K. , Hasegawa , T. , Iwasaki , N. , Kakiuchi , M. and Kato , H.Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1‐ or 7‐position . J. Med. Chem. , 36 , 1380 – 1386 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Miyamoto , K. , Sakai , R. , Kurita , M. , Ohmae , S. , Sanae , F. , Sawanishi , H. , Hasegawa , T. and Takagi , K.Effects of alkyl substituents of xanthine on phosphodiesterase isoenzymes . Biol. Pharm. Bull. , 18 , 431 – 434 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Takagi , K. , Hasegawa , T. , Kuzuya , T. , Ogawa , K. , Watanabe , T. , Satake , T. , Miyamoto , M. , Wakusawa , S. and Koshiura , R.Structure‐activity relationship in N3‐alkylxanthine derivatives . Jpn. J. Pharmacol. , 46 , 373 – 378 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Sanae , F. , Ohmae , S. , Kurita , M. , Sawanishi , H. , Takagi , K. and Miyamoto , K.Structure‐activity relationships of alkylxanthines: alkyl chain elongation at the N1 or N7‐position decreases cardiotopic activity in the isolated guinea‐pig heart . Jpn. J. Pharmacol. , 69 , 75 – 82 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Berman , E. and McBride , M.Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrugresistant leukemia cells . Blood , 79 , 3267 – 3273 ( 1992. ). [PubMed] [Google Scholar]
- 20. ) Gallois , L. , Fiallo , M. and Garnier‐Suillerot , A.Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles: circular dichroism study . Biochim. Biophys. Acta , 1370 , 31 – 40 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Nagasawa , K. , Ohnishi , N. and Yokoyama , T.Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs . Jpn. J. Cancer Res. , 88 , 750 – 759 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. ) Nagasawa , K. , Ohnishi , N. and Yokoyama , T.Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells . Jpn. J. Cancer Res. , 89 , 673 – 680 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. ) Nagasawa , K. , Fumihara , T. , Ohnishi , N. and Yokoyama , T.Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells . Jpn. J. Cancer Res. , 90 , 781 – 787 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. ) Plagemann , P. G. W. , Wohlhueter , R. M. and Woffendin , C.Nucleoside and nucleobase transport in animal cells . Biochim. Biophys. Acta , 947 , 405 – 443 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 25. ) Griffith , D. A. and Jarvis , S. M.Nucleoside and nucleobase transport systems of mammalian cells . Biochim. Biophys. Acta , 1286 , 153 – 181 ( 1996. ). [DOI] [PubMed] [Google Scholar]